Underweight: Trim 10-15% targeting 60% residual through Q3 binary catalyst
Underweight maintained with 10-15% trim anchored to the 10/05 reflection's 5-10pp guidance for this setup family (price absorbed technical breakdown, buyback machinery engaged below). The 60% residual cap preserves buyback-floor optionality per the 9/24 lesson while capping alpha bleed. Full Sell rejected per 9/24 buyback floor ($4.68B/quarter, $122.7B equity cushion, 16.9% ROE). Pure Hold rejected per 10/02 and 9/29 reflections. Covered-call overlay and fresh adds below $952 rejected per 9/11 and 9/4 lessons respectively. Expected alpha: single-digit bps in either direction through Q3 print per 9/28.
| Position | Action |
|---|---|
| Price at $913-$952 resistance band (10 EMA at $913.75 / 200 SMA at $952.46) | Trim 10-15% of GS position, scaling over 2-3 sessions, targeting residual ~60% of benchmark weight |
| Residual position approaches full exit | Hard stop at $970 daily close (structural invalidation above 200 SMA) |
| Weekly close below $857 (lower Bollinger Band) on expansion volume | Full-exit review |
Goldman Sachs represents a classic "great company, bad tape" dislocation where a 92% YoY earnings acceleration has been ignored by a tape fixated on lagging price indicators, creating a generational entry point at 12.4x forward P/E on a premier capital markets franchise.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 913.75 | bearish |
| close_50_sma | 994.89 | bearish |
| close_200_sma | 952.46 | bearish |
| rsi | 32.02 | neutral |
| macd | -31.64 | bearish |
| macds | -28.62 | bearish |
| macdh | -3.01 | bullish |
| boll | 945.05 | neutral |
| boll_ub | 1032.44 | bearish |
| boll_lb | 857.66 | bullish |
| atr | 22.70 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 print >$19 EPS AND stock holds $952 through the print
Then: Reassess to Overweight
EV: +3:1 risk/reward to 200 SMA ($952) · concedes: Consumer credit risk (Marcus, Apple Card exposure) is a real concern — not disputed; Bear's macro concerns about US debt sustainability and consumer credit deterioration are valid in direction; Consumer exposure is a fraction of earnings mix; the bear's macro concerns are already priced into the 12.4x multiple; The bull thesis does not require credit conditions to improve — only that they don't get materially worse; At 6% recession probability, that bar is easily cleared
Goldman Sachs is at peak-cycle earnings with a structurally broken technical trend, and the market is correctly pricing mean reversion as forward estimates face downward revision from a hawkish Fed, AFS mark pressures, credit normalization, and the firm's own bearish research on debt sustainability.
EV: $0 (zero edge to upside) · concedes: Q2'26 earnings are accelerating (TRUE — but cyclically peak); Valuation appears cheap at 12.4x forward P/E (TRUE — only because forward EPS won't be hit)
→ vs conservative: Fortress balance sheet narrative ($187B cash, $2.13T assets, $100B tangible book, 16.9% ROE) is irrelevant when price breaks below all moving averages; balance sheet quality does not prevent structural breakdown
→ vs conservative: Q2'26 earnings beat was manufactured by tax rate anomaly, not underlying earnings power; buying into juiced numbers is catching a falling knife
→ vs conservative: 12.4x forward P/E is not cheap when the forward EPS is about to be revised down and is based on peak inflated numbers
→ vs neutral: Absence of coverage before earnings is not a reason to wait passively; neutral sentiment at 5/10 with quiet retail and empty institutional coverage is a reason to position aggressively before the Q3 report
→ vs neutral: Waiting for a clear signal means missing the trim opportunity at 913-952; by the time the signal is clear, GS will be at 880 or lower
Support: 857.66 · 881 · 893.46 | Resistance: 913.75 · 945.05 · 952.46 · 994.89 · 1032.44
GS has broken decisively below the 200 SMA (952.46) with the 50 SMA (994.89) and 200 SMA both rolling over, confirming a meaningful corrective phase with a peak-to-trough drawdown of approximately -23.3% from the July 2026 high of 1,148.37. While the MACD histogram compression (-9.18 to -3.01) and ATR decline (29.42 to 22.70) suggest selling exhaustion, a confirmed reversal requires reclaiming the 200 SMA on a closing basis. Key support sits at 881.00 with the Bollinger lower band at 857.66 as the capitulation line; first resistance on any bounce is the 10 EMA at 913.75.
Market Capitalization
$261.23B
Share Price (implied)
~$896
Shares Outstanding
291.4M
52-Week High
$1,153.99
52-Week Low
$740.01
50-Day MA
$1,000.43
200-Day MA
$959.78
Dividend Yield
2.24%
Beta
1.28
Book Value / Share
$362.05
Trailing P/E
13.86x
Forward P/E
12.37x
PEG Ratio
1.10
Price / Book
2.48x
Q2'25 Revenue
$14,583M
Q3'25 Revenue
$15,184M
Q4'25 Revenue
$13,454M
Q1'26 Revenue
$17,227M
Q2'26 Revenue
$20,338M
Q2'25 Net Interest Income
$3,104M
Q3'25 Net Interest Income
$3,852M
Q4'25 Net Interest Income
$3,708M
Q1'26 Net Interest Income
$3,555M
Q2'26 Net Interest Income
$3,954M
Q2'25 Pretax Income
$4,958M
Q3'25 Pretax Income
$5,392M
Q4'25 Pretax Income
$5,855M
Q1'26 Pretax Income
$6,486M
Q2'26 Pretax Income
$8,563M
Q2'25 Net Income
$3,723M
Q3'25 Net Income
$4,098M
Q4'25 Net Income
$4,617M
Q1'26 Net Income
$5,630M
Q2'26 Net Income
$6,628M
Q2'25 Diluted EPS
$10.91
Q3'25 Diluted EPS
$12.25
Q4'25 Diluted EPS
$14.01
Q1'26 Diluted EPS
$17.55
Q2'26 Diluted EPS
$20.98
Q2'25 Effective Tax Rate
24.9%
Q3'25 Effective Tax Rate
24.0%
Q4'25 Effective Tax Rate
21.1%
Q1'26 Effective Tax Rate
13.2%
Q2'26 Effective Tax Rate
22.6%
Operating Margin
42.2%
Net Profit Margin
31.0%
ROE
16.9%
ROA
1.07%
Q2'25 Total Assets
$1,785,009M
Q3'25 Total Assets
$1,807,982M
Q4'25 Total Assets
$1,809,320M
Q1'26 Total Assets
$2,060,180M
Q2'26 Total Assets
$2,127,711M
Q2'25 Total Liabilities
$1,660,913M
Q3'25 Total Liabilities
$1,683,580M
Q4'25 Total Liabilities
$1,684,348M
Q1'26 Total Liabilities
$1,937,398M
Q2'26 Total Liabilities
$2,004,969M
Q2'25 Stockholders Equity
$124,096M
Q3'25 Stockholders Equity
$124,402M
Q4'25 Stockholders Equity
$124,972M
Q1'26 Stockholders Equity
$122,782M
Q2'26 Stockholders Equity
$122,742M
Q2'25 Common Equity
$108,943M
Q3'25 Common Equity
$109,249M
Q4'25 Common Equity
$109,819M
Q1'26 Common Equity
$109,079M
Q2'26 Common Equity
$109,714M
Q2'25 Tangible Book Value
$102,103M
Q3'25 Tangible Book Value
$102,435M
Q4'25 Tangible Book Value
$103,028M
Q1'26 Tangible Book Value
$101,557M
Q2'26 Tangible Book Value
$100,443M
Q2'25 Total Debt
$372,977M
Q3'25 Total Debt
$376,267M
Q4'25 Total Debt
$386,150M
Q1'26 Total Debt
$434,737M
Q2'26 Total Debt
$475,019M
Q2'25 Net Debt
$217,856M
Q3'25 Net Debt
$204,506M
Q4'25 Net Debt
$219,721M
Q1'26 Net Debt
$253,110M
Q2'26 Net Debt
$285,689M
Q2'25 Cash & Equivalents
$152,967M
Q3'25 Cash & Equivalents
$169,577M
Q4'25 Cash & Equivalents
$164,259M
Q1'26 Cash & Equivalents
$179,530M
Q2'26 Cash & Equivalents
$187,266M
Q2'25 Trading Securities
$571,863M
Q3'25 Trading Securities
$600,320M
Q4'25 Trading Securities
$445,202M
Q1'26 Trading Securities
$512,660M
Q2'26 Trading Securities
$538,593M
Q2'25 Available-for-Sale
$125,673M
Q3'25 Available-for-Sale
$118,933M
Q4'25 Available-for-Sale
$120,452M
Q1'26 Available-for-Sale
$158,525M
Q2'26 Available-for-Sale
$173,644M
Q2'25 Receivables
$200,527M
Q3'25 Receivables
$195,578M
Q4'25 Receivables
$205,739M
Q1'26 Receivables
$229,165M
Q2'26 Receivables
$250,330M
Q2'25 Operating Cash Flow
$5,672M
Q3'25 Operating Cash Flow
$2,680M
Q4'25 Operating Cash Flow
($16,276M)
Q1'26 Operating Cash Flow
($31,868M)
Q2'26 Operating Cash Flow
$6,105M
Q2'25 Free Cash Flow
$5,196M
Q3'25 Free Cash Flow
$2,122M
Q4'25 Free Cash Flow
($16,807M)
Q1'26 Free Cash Flow
($32,433M)
Q2'26 Free Cash Flow
$5,603M
Q2'25 CapEx
($476M)
Q3'25 CapEx
($558M)
Q4'25 CapEx
($531M)
Q1'26 CapEx
($565M)
Q2'26 CapEx
($502M)
Q2'25 Dividends Paid
($1,223M)
Q3'25 Dividends Paid
($1,476M)
Q4'25 Dividends Paid
($1,463M)
Q1'26 Dividends Paid
($1,588M)
Q2'26 Dividends Paid
($1,603M)
Q2'25 Buybacks
($3,000M)
Q3'25 Buybacks
($2,000M)
Q4'25 Buybacks
($3,000M)
Q1'26 Buybacks
($6,450M)
Q2'26 Buybacks
($4,675M)
Q2'25 Net Debt Issuance
$677M
Q3'25 Net Debt Issuance
($1,554M)
Q4'25 Net Debt Issuance
$8,836M
Q1'26 Net Debt Issuance
$52,886M
Q2'26 Net Debt Issuance
$39,546M
Q2'25 Unusual Items
($1M)
Q3'25 Unusual Items
($131M)
Q4'25 Unusual Items
($278M)
Q1'26 Unusual Items
($42M)
Q2'26 Unusual Items
$28M
TTM EPS
$64.75
Forward EPS
$72.55
Q2'26 Compensation Expense
~$6.1B
Compensation as % of Revenue
~30%
Revenue YoY Growth (Q2'26)
+39%
Net Income YoY Growth (Q2'26)
+78%
Asset Growth YoY
+19%
Cash Growth YoY
+22%
Annualized Capital Return (2026)
~$19.6B
Strengths
Concerns
Goldman Sachs is in a fundamental acceleration phase with Q2'26 delivering record revenue of $20.3B and EPS of $20.98, representing approximately 92% YoY EPS growth. The combination of expanding net interest income (up 27% YoY), growing balance sheet ($2.13T in assets, +19% YoY), strong profitability (42.2% operating margin, 16.9% ROE), and active capital return (~$19.6B annualized run rate) creates an attractive fundamental setup. However, the stock trades below both its 50-day ($1,000.43) and 200-day ($959.78) moving averages with elevated beta (1.28), suggesting either a market overreaction opportunity or concerns about sustainability of recent momentum amid high cyclicality risks.
Macro: "Higher for Longer" macro regime with hawkish Fed tilt: 96% probability of NO Fed rate cuts in 2026 per Polymarket ($8.8M volume); 10Y Treasury touched highest level since 2002 (23-year highs); US recession probability at 6% ($2.27M volume), UK 7%, Japan 4%; Iran war driving above-target inflation with second-round effects; September jobs report miss caused modest Treasury easing but has not flipped near-term policy stance; equity markets (S&P 500, Nasdaq) at record highs despite macro headwinds, suggesting low realized vol and complacent positioning.